The idea that the carnivore diet heals the gut by removing plants runs counter to what we know from modern nutrition science
"Best For" Scenarios Because we do not declare a single "winner," we have identified the specific scenarios where one provider stands out based on our weighted methodology and each platforms current July 2026 positioning
First cardiovascular safety trial of a DPP-4 inhibitor in patients with T2DM and high cardiovascular risk, showing that saxagliptin does not augment MACE but increases hospitalization for heart failure
Protective effect of sitagliptin against renal ischemia reperfusion injury in rats
Thomas DM, Martin CK, Heymsfield S, Redman LM, Schoeller DA, Levine JA
This is now going back to 1997 with approval in 2010, still 14 years ago